VNDA

VNDA

Vanda Pharmaceuticals Inc. Common Stock

$4.590+-0.000 (-0.000%)

Reaalajas hind

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$4.590

Kõrge

$4.590

Madal

$4.590

Maht

0.18M

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Seotud uudised

PR Newswire

Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Society of Clinical Psychopharmacology (ASCP) Annual...

Vaata rohkem
Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting
PR Newswire

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro &...

Vaata rohkem
Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
Analyst Upgrades

Cantor Fitzgerald Assumes Vanda Pharmaceuticals at Overweight, Announces Price Target of $13

Cantor Fitzgerald analyst Olivia Brayer assumes Vanda Pharmaceuticals with a Overweight rating and announces Price Target of $13.

Vaata rohkem
Cantor Fitzgerald Assumes Vanda Pharmaceuticals at Overweight, Announces Price Target of $13
PR Newswire

Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2025....

Vaata rohkem
Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results